Ecstasy to treat PTSD by 2021? US FDA approves Ph III trial
Party drug MDMA has been claimed to be effective in helping treat Post-traumatic stress disorder (PTSD) patients, with the FDA approval for a Ph III trial to go ahead in the US.
Archives for December 1, 2016
Operator silence rings alarm bells during audits, say FDA and WHO experts
Full transparency and open conversation with operators will lead to more successful facility audits, say regulatory experts.
Spain's Idifarma adds capsule filling to service offerings
Idifarma has invested over €300,000 in its facility in Spain in order to offer its customers automated capsule filling for commercial batches.
Takeda building Dengue fever vaccine plant
Takeda has started work on a vaccine plant to make its candidate Dengue fever virus vaccine, TAK-003.